|
1
|
Fattizzo B and Barcellini W: Autoimmune
hemolytic anemia: Causes and consequences. Expert Rev Clin Immunol.
18:731–745. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barcellini W and Fattizzo B: Autoimmune
hemolytic anemias: Challenges in diagnosis and therapy. Transfus
Med Hemother. 51:321–331. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arias de la Vega F, Torres López A, Piedra
Roset P, Barco Burguete A, Rosas Gutiérrez L and Sola Galarza A:
Paraneoplastic hemolytic anemia associated with prostate cancer. A
case report. An Sist Sanit Navar. 45:e10232022.(In Spanish).
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Isotani S, Horiuchi A, Koja M, Noguchi T,
Sugiura S, Shimoyama H, Noma Y, Kitamura K, China T, Tokiwa S, et
al: Autoimmune hemolytic anemia associated with renal urothelial
cancer: A case report and literature review. BMC Urol. 15:752015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zemek L, Strom L, Gordon G and Elguezabel
A: Hemolytic anemia with Kaposi's sarcoma. Report of a case JAMA.
187:232–234. 1964.PubMed/NCBI
|
|
6
|
Loh KP, Kansagra A, Asik A, Ali S and
Dahiya S: Paraneoplastic autoimmune hemolytic anemia in ovarian
cancer: A marker of disease activity. Rare Tumors. 7:55982015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Puthenparambil J, Lechner K and Kornek G:
Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid
tumors: A critical analysis of 52 cases reported in the literature.
Wien Klin Wochenschr. 122:229–236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berta DM, Teketelew BB, Chane E, Bayleyegn
B, Tamir M, Cherie N, Seyoum M, Mekuanint A and Aynalem M:
Hematological changes in women with cervical cancer before and
after cancer treatment: Retrospective cohort study. Sci Rep.
14:276302024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhatla N, Berek JS, Cuello Fredes M, Denny
LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB,
Prat J, et al: Revised FIGO staging for carcinoma of the cervix
uteri. Int J Gynaecol Obstet. 145:129–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Loriamini M, Cserti-Gazdewich C and Branch
DR: Autoimmune hemolytic anemias: Classifications, pathophysiology,
diagnoses and management. Int J Mol Sci. 25:42962024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kamesaki T: Autoimmune hemolytic anemia as
a paraneoplastic syndrome associated with solid tumors. Rinsho
Ketsueki. 56:778–784. 2015.(In Japanese). PubMed/NCBI
|
|
12
|
Zeger G, Smith L, McQuiston D and
Goldfinger D: Cisplatin-induced nonimmunologic adsorption of
immunoglobulin by red cells. Transfusion. 28:493–495. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dacha S, Reddivari AK, Latta S, Devidi M
and Iroegbu N: Carboplatin induced fatal autoimmune hemolytic
anemia: First reported case. World J Oncol. 1:173–175.
2010.PubMed/NCBI
|
|
14
|
Nguyen TN, Maenulein E, Fihman V, Vinatier
I and Moh Klaren J: Serologic characteristics of oxaliplatin
antibodies in 15 patients with drug-induced immune hemolytic
anemia. Transfusion. 61:1609–1616. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu H, Wang N, Wang P, Zhang H, Zhao R, Liu
H, He X, Liu Z, Chang Y, Cao Y and Wang S: Case report: First case
of pemetrexed plus cisplatin-induced immune hemolytic anemia in a
patient with lung adenocarcinoma. Front Med (Lausanne).
9:9174852022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Getaz EP, Beckley S, Fitzpatrick J and
Dozier A: Cisplatin-induced hemolysis. N Engl J Med. 302:334–335.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kitao A, Kawamoto S, Kurata K, Hayakawa I,
Yamasaki T, Matsuoka H, Sumi Y, Kakeji Y, Kamesaki T and Minami H:
Band 3 ectopic expression in colorectal cancer induces an increase
in erythrocyte membrane-bound IgG and may cause immune-related
anemia. Int J Hematol. 111:657–666. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ochiai T, Yasuda H, Akiba H, Ashizawa K,
Hosoya E, Ando J, Miyake S and Ando M: Ectopic band 3 expression as
a cause of mature ovarian teratoma-associated secondary autoimmune
hemolytic anemia. Int J Lab Hematol. 46:744–746. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel NY, Chilsen AM, Mathiason MA,
Kallies KJ and Bottner WA: Outcomes and complications after
splenectomy for hematologic disorders. Am J Surg. 204:1014–1020.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bortolotti M, Barcellini W and Fattizzo B:
Molecular pharmacology in complement-mediated hemolytic disorders.
Eur J Haematol. 111:326–336. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barcellini W and Fattizzo B: How I treat
warm autoimmune hemolytic anemia. Blood 137: 1283–1294, 2021.
Erratum in [No authors listed] Blood. 438–439. 2023.
|
|
22
|
Fattizzo B, Cantoni S, Giannotta JA,
Bandiera L, Zavaglia R, Bortolotti M and Barcellini W: Efficacy and
safety of cyclosporine A treatment in autoimmune cytopenias: The
experience of two Italian reference centers. Ther Adv Hematol.
13:204062072210977802022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Agrawal K and Alfonso F: A rare
association of autoimmune hemolytic anemia with gastric
adenocarcinoma. Case Rep Oncol Med. 2017:84146022017.PubMed/NCBI
|
